Oryzon reveals positive data from anti-aggression drug vafidemstat
Oryzon Genomics has announced new aggregated positive human efficacy data on its central nervous system (CNS) epigenetic drug vafidemstat from…
Oryzon Genomics has announced new aggregated positive human efficacy data on its central nervous system (CNS) epigenetic drug vafidemstat from…